Sernova Corp. Appoints Jonathan Rigby as Executive Chairman
Chief Executive Officer, will continue in her role as originally defined managing Sernova's day to day business strategy and operations; she will continue to report to the Board. Mr. Rigby has held several CEO roles and currently serves on the Board of Directors of cancer therapy company Oncolytics Biotech Inc. and IM Therapeutics and was formerly on the board of Xeris Pharmaceuticals. Mr. Rigby holds a degree in Biological Sciences from the University of Sheffield, UK, and has a Master of Business Administration degree from the University of Portsmouth, UK.